CD274 and neoplasm: Research shows that cellular progression, such as aging, affects the expression of PD-L1 at immune checkpoints (38), so that we speculated that whether MLN8237 could influence the immune response of the tumor by regulating PD-L1 expression while inhibiting the cell cycle.